Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System
Dexcom announces the launch of its G7 Continuous Glucose Monitoring (CGM) System in the UK, Ireland, Germany, Austria, and Hong Kong, aimed at people aged two and older. The G7 features the fastest sensor warmup in the market, with no finger sticks required, and builds on the accuracy of Dexcom's previous products. A global streaming launch event showcased the device, with plans for launches in New Zealand and South Africa soon. With improved design and integration into automated insulin delivery systems, Dexcom G7 marks a significant advancement in diabetes management.
- Launch of Dexcom G7 in multiple key markets including UK, Ireland, Germany, Austria, and Hong Kong.
- Fastest sensor warmup time of 30 minutes in the market.
- No finger sticks required for monitoring, enhancing user experience.
- Plans for upcoming launches in New Zealand and South Africa.
- Integration with automated insulin delivery systems in progress.
- None.
-
People with diabetes in the
United Kingdom ,Ireland ,Germany ,Austria andHong Kong can get started with Dexcom G7 now -
The new CGM system is also expected to launch in
New Zealand andSouth Africa in the weeks ahead, with additional markets planned soon after - A global, streaming launch event held today revealed an inside look at Dexcom G7 through the eyes of company leadership, the G7 project team and Dexcom Warriors from around the world
- Dexcom G7 has the fastest sensor warmup on the market,* with no finger sticks† or scanning required, and builds on the unparalleled accuracy of Dexcom CGM1 that is supported by more peer reviewed, clinical research than any other CGM
Dexcom G7 offers a powerful yet simple way to help users gain greater control of their diabetes (Photo: Business Wire)
“Since Dexcom G6 came to market, we’ve eliminated over 15 billion fingerpricks‡ and helped improve the lives of more than 1.25 million people with diabetes around the world. We’re thrilled to begin the global rollout of Dexcom G7, our next-generation CGM technology, that vastly improves upon what everyone loves about G6,” said
To introduce the highly anticipated new device, earlier today
“There were so many times, especially when Ava was first diagnosed, that our lives had to fit around the disease, and not the other way around,” said
The event also included comments from
“Dexcom customers from around the world were a part of the G7 design process,” said Diener, who helped design G7 and lives with Type 1 diabetes. “We learned from people living with Type 1 and Type 2 diabetes, younger and older patients, and their caregivers, about the CGM features they need to allow them to focus more on their everyday lives and less on managing diabetes.”
The streaming launch event can be viewed on demand at DexcomEvent.com.
Dexcom G7: The Most Powerful CGM on the Market
Dexcom G7 offers a powerful yet simple way to help users gain greater control of their diabetes, so they can manage the disease more confidently each day. Its low-profile, all-in-one wearable warms up faster than any other CGM on the market,* sending real-time glucose readings automatically to a compatible smart device§ or receiver, no painful finger sticks† or burdensome scanning required.
Dexcom G7 builds on the trusted performance of Dexcom CGM, which is clinically proven to lower A1C and reduce hyper- and hypoglycemia.||,1 Its customizable alerts can warn of high or low glucose levels and help users spend more time in range.||,2 Industry-leading remote monitoring and reporting capabilities also allow users to stay connected with their loved ones and care teams anytime, anywhere.
New features with Dexcom G7:
|
Dexcom G6 features included with Dexcom G7:
|
To learn more about Dexcom G7 visit DexcomEvent.com. For further details on Dexcom CGM, visit Dexcom.com.
About
*Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.
†If your glucose alerts and readings from Dexcom G7 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
‡
§To view a list of compatible smart devices, visit dexcom.com/compatibility
||Results obtained with a prior generation Dexcom CGM System.
Separate Dexcom Follow app and internet connection required. Internet connectivity required for data sharing. Users should always confirm readings on the Dexcom G7 app or receiver before making treatment decisions.
#Healthcare providers can register for Dexcom Clarity at clarity.dexcom.com/professional/registration.
**An internet connection is required for patients to send their glucose data to Dexcom Clarity via a compatible smart device: dexcom.com/compatibility. Healthcare providers will only be able to view a patient’s glucose data if the patient elects to share it with them through Dexcom Clarity.
††Pending 510(k) clearance -- Not available for sale in the
1 Beck RW, et al. JAMA. 2017;317(4):371-378.
2 Welsh JB, et al. Diabetes Technol Ther. 2019;21(3):128-132.
3 Dexcom G7 User Guide.
© 2022
View source version on businesswire.com: https://www.businesswire.com/news/home/20221004005386/en/
Media Contact
619-884-2118
james.mcintosh@dexcom.com
Investor Contact
858-203-6657
sean.christensen@dexcom.com
Source:
FAQ
When was the Dexcom G7 launched?
Which countries are included in the Dexcom G7 launch?
What is unique about the Dexcom G7 Continuous Glucose Monitoring System?
Are there plans for the Dexcom G7 to expand into other markets?